Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies
-
Published:2020-10-30
Issue:1
Volume:36
Page:37-55
-
ISSN:0393-2990
-
Container-title:European Journal of Epidemiology
-
language:en
-
Short-container-title:Eur J Epidemiol
Author:
van den Brandt Piet A.ORCID, Ziegler Regina G., Wang Molin, Hou Tao, Li Ruifeng, Adami Hans-Olov, Agnoli Claudia, Bernstein Leslie, Buring Julie E., Chen Yu, Connor Avonne E., Eliassen A. Heather, Genkinger Jeanine M., Gierach Gretchen, Giles Graham G., Goodman Gary G., Håkansson Niclas, Krogh Vittorio, Le Marchand Loic, Lee I-Min, Liao Linda M., Martinez M. Elena, Miller Anthony B., Milne Roger L., Neuhouser Marian L., Patel Alpa V., Prizment Anna, Robien Kim, Rohan Thomas E., Sawada Norie, Schouten Leo J., Sinha Rashmi, Stolzenberg-Solomon Rachael Z., Teras Lauren R., Tsugane Shoichiro, Visvanathan Kala, Weiderpass Elisabete, White Kami K., Willett Walter C., Wolk Alicja, Zeleniuch-Jacquotte Anne, Smith-Warner Stephanie A.
Abstract
AbstractAssociations between anthropometric factors and breast cancer (BC) risk have varied inconsistently by estrogen and/or progesterone receptor (ER/PR) status. Associations between prediagnostic anthropometric factors and risk of premenopausal and postmenopausal BC overall and ER/PR status subtypes were investigated in a pooled analysis of 20 prospective cohorts, including 36,297 BC cases among 1,061,915 women, using multivariable Cox regression analyses, controlling for reproductive factors, diet and other risk factors. We estimated dose–response relationships and tested for nonlinear associations using restricted cubic splines. Height showed positive, linear associations for premenopausal and postmenopausal BC risk (6–7% RR increase per 5 cm increment), with stronger associations for receptor-positive subtypes. Body mass index (BMI) at cohort baseline was strongly inversely associated with premenopausal BC risk, and strongly positively—and nonlinearly—associated with postmenopausal BC (especially among women who never used hormone replacement therapy). This was primarily observed for receptor-positive subtypes. Early adult BMI (at 18–20 years) showed inverse, linear associations for premenopausal and postmenopausal BC risk (21% and 11% RR decrease per 5 kg/m2, respectively) with stronger associations for receptor-negative subtypes. Adult weight gain since 18–20 years was positively associated with postmenopausal BC risk, stronger for receptor-positive subtypes, and among women who were leaner in early adulthood. Women heavier in early adulthood generally had reduced premenopausal BC risk, independent of later weight gain. Positive associations between height, baseline (adult) BMI, adult weight gain and postmenopausal BC risk were substantially stronger for hormone receptor-positive versus negative subtypes. Premenopausal BC risk was positively associated with height, but inversely with baseline BMI and weight gain (mostly in receptor-positive subtypes). Inverse associations with early adult BMI seemed stronger in receptor-negative subtypes of premenopausal and postmenopausal BC.
Funder
Maastricht University Medical Center
Publisher
Springer Science and Business Media LLC
Reference82 articles.
1. van den Brandt PA, Spiegelman D, Yaun SS, et al. A pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514–27. 2. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78. https://doi.org/10.1016/S0140-6736(08)60269-X. 3. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev. 2001;23(2):313–42. 4. Green J, Cairns BJ, Casabonne D, et al. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol. 2011;12(8):785–94. https://doi.org/10.1016/S1470-2045(11)70154-1. 5. Zhang B, Shu XO, Delahanty RJ, et al. Height and breast cancer risk: evidence from prospective studies and mendelian randomization. J Natl Cancer Inst. 2015. https://doi.org/10.1093/jnci/djv219.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|